19th Clinical Trials on Alzheimer's Disease (CTAD) 2026
Talk
Late Breaking Symposium 1
Tue, Nov 17, 2026 · 4:45–5:25 PM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Additional biomarker and clinical findings from the Phase 2 CELIA study of diranersen in early Alzheimer's disease (Biogen).